Stocks and Investing
Stocks and Investing
Thu, March 5, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Adam Maeder Reiterated (AXNX) at Buy with Increased Target to $48 on, Mar 5th, 2020
Adam Maeder of Piper Sandler, Reiterated "Axonics, Inc." (AXNX) at Buy with Increased Target from $44 to $48 on, Mar 5th, 2020.
Adam has made no other calls on AXNX in the last 4 months.
There is 1 other peer that has a rating on AXNX. Out of the 1 peers that are also analyzing AXNX, 0 agree with Adam's Rating of Hold.
This is the rating of the analyst that currently disagrees with Adam
- David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $42 on, Friday, November 15th, 2019